Statistical issues in clinical trial design

Kenneth R. Hess

doi:10.1007/BF02951426

Statistical issues in clinical trial design

Kenneth R. Hess

Biostatistics

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

This paper reviews some of the more salient recent developments in statistical aspects of clinical trial design methodology and suggests that more emphasis be placed on rigorous assessments of the new methodologies to place them in the context of existing methods, demonstrate their claimed advantages, and fully disclose their remaining limitations.

Original language	English (US)
Pages (from-to)	55-59
Number of pages	5
Journal	Current oncology reports
Volume	9
Issue number	1
DOIs	https://doi.org/10.1007/BF02951426
State	Published - Jan 2007

ASJC Scopus subject areas

Oncology

MD Anderson CCSG core facilities

Biostatistics Resource Group

Access to Document

10.1007/BF02951426

Cite this

@article{87231d0899a9408ca9a1dd4b8ad776a6,

title = "Statistical issues in clinical trial design",

abstract = "This paper reviews some of the more salient recent developments in statistical aspects of clinical trial design methodology and suggests that more emphasis be placed on rigorous assessments of the new methodologies to place them in the context of existing methods, demonstrate their claimed advantages, and fully disclose their remaining limitations.",

author = "Hess, {Kenneth R.}",

year = "2007",

month = jan,

doi = "10.1007/BF02951426",

language = "English (US)",

volume = "9",

pages = "55--59",

journal = "Current oncology reports",

issn = "1523-3790",

publisher = "Current Science, Inc.",

number = "1",

}

TY - JOUR

T1 - Statistical issues in clinical trial design

AU - Hess, Kenneth R.

PY - 2007/1

Y1 - 2007/1

N2 - This paper reviews some of the more salient recent developments in statistical aspects of clinical trial design methodology and suggests that more emphasis be placed on rigorous assessments of the new methodologies to place them in the context of existing methods, demonstrate their claimed advantages, and fully disclose their remaining limitations.

AB - This paper reviews some of the more salient recent developments in statistical aspects of clinical trial design methodology and suggests that more emphasis be placed on rigorous assessments of the new methodologies to place them in the context of existing methods, demonstrate their claimed advantages, and fully disclose their remaining limitations.

UR - http://www.scopus.com/inward/record.url?scp=33846163149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846163149&partnerID=8YFLogxK

U2 - 10.1007/BF02951426

DO - 10.1007/BF02951426

M3 - Review article

C2 - 17164048

AN - SCOPUS:33846163149

SN - 1523-3790

VL - 9

SP - 55

EP - 59

JO - Current oncology reports

JF - Current oncology reports

IS - 1

ER -

Statistical issues in clinical trial design

Abstract

ASJC Scopus subject areas

MD Anderson CCSG core facilities

Access to Document

Other files and links

Fingerprint

Cite this